Cellmid Limited Logo

Cellmid Limited

Suite 1802, Level 18 15 Castlereagh Stree, SYDNEY NSW 2000

no rating

73 Visits
  

Medical Services - Sydney, NSW

Cellmid Limited (ASX:CDY) is an Australian biotechnology company developing first in class antibodies against the novel target midkine (MK).

Cellmid Limited (ASX:CDY) is an Australian biotechnology company developing first in class antibodies against the novel target midkine (MK).

Cellmid holds the largest and most comprehensive portfolio of intellectual property related to the growth factor midkine (neurite growth-promoting factor 2). Midkine is an extensively validated therapeutic and diagnostic target in cancer, inflammation and auto-immune disorders.

Cellmid is actively seeking partners to commercialise these significant intellectual property assets in cancer, ischemia, and inflammatory diseases.

Sign in with Email
Top4 - Made in Australia with Love
Stay In Touch